Galway, Ireland, Sept. 5, 2009 – AOTI Ltd. announced today that it will showcase its revolutionary wound care products at the upcoming ETRS/ WHS meeting in Bled, Slovenia, Sept 25-29.
“The Joint Meeting of the ETRS and WHS provides AOTI an ideal venue to demonstrate the therapeutic and economic value of our Topical Wound Oxygen (TWO2) products to those key medical professionals and opinion leaders throughout Central and Eastern Europe, stated Kevin Plihal VP Marketing and Business Development for AOTI.” Our TWO2 therapy addresses the fundamental reasons chronic wounds do not heal, by reducing pathogenic bio-burdens and reversing the localized tissue hypoxia, thereby stimulating the underlying cellular mechanisms needed for good tissue to regenerate.”
AOTI is founded on a decade of experience in providing innovative solutions to resolve severe and chronic wounds worldwide. Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses. Our patented non-invasive Topical Wound Oxygen (two2) therapy is unsurpassed in fully closings Diabetic, Venous and Pressure ulcers alike. AOTI is a private company based in Galway, Ireland with offices throughout the globe. For more information, see www.aotinc.net.